{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/650315b3a02e020011aea566/69e8feff23929c3a2a919e3d?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The Broken Ecosystem: What It Will Actually Take to Change Women's Health","description":"<p><a href=\"https://www.linkedin.com/in/dr-chrysi-sergaki-a387b4127/\" rel=\"noopener noreferrer\" target=\"_blank\">Dr Chrysi Sergaki</a> is the founder and CEO of <a href=\"https://xxinnovation.com/\" rel=\"noopener noreferrer\" target=\"_blank\">XX Innovation</a>, a not-for-profit organisation driving systems change in women's health. With seven years at the Medicines and Healthcare Products Regulatory Agency (MHRA), she brings deep experience across policy, regulation, research, innovation and investment — and a rare ability to align the full range of stakeholders needed to drive real change. Her pivot to XX Innovation came after writing a landmark paper on the untapped potential of vaginal microbiome diagnostics, which opened her eyes to just how fragmented the women's health ecosystem truly is.</p><p><br></p><h2>What We Covered</h2><p><strong>The real meaning of ecosystem</strong> — why the term is routinely misused to mean just startups and investors, and why that framing is part of the problem.</p><p><strong>Fragmentation across the full pathway</strong> — from regulation and NHS access through to investment incentives and patient involvement, and why each breakdown point needs its own solution.</p><p><strong>Regulation is not the enemy</strong> — why the fear of the regulatory process is a perception problem, not a reality, and why it is never too early for founders to engage with the MHRA.</p><p><strong>Misaligned investment incentives</strong> — why the lack of a clear return pathway pushes companies toward wellness when the real need is diagnostics and therapeutics.</p><p><strong>The knowledge gap</strong> — how little we still understand about female physiology, and why that blocks meaningful progress across the whole system.</p><p><strong>Advice for founders</strong> — decide who you are, engage the regulator early, think about your clinical validation, and always centre the patient.</p><p><strong>Accountability in action</strong> — why enthusiasm without follow-through is noise, and how to test partners early with small concrete actions.</p><h2>Resources &amp; Links</h2><ul><li>🌐 <a href=\"https://xxinnovation.com/\" rel=\"noopener noreferrer\" target=\"_blank\">XX Innovation website</a></li><li>💼 <a href=\"https://www.linkedin.com/in/dr-chrysi-sergaki-a387b4127/\" rel=\"noopener noreferrer\" target=\"_blank\">Dr Chrysi on LinkedIn</a></li><li>💼 <a href=\"https://www.linkedin.com/company/xx-innovation/posts/?feedView=all\" rel=\"noopener noreferrer\" target=\"_blank\">XX Innovation on LinkedIn</a></li><li>📸 <a href=\"https://www.instagram.com/xxinnovation/\" rel=\"noopener noreferrer\" target=\"_blank\">XX Innovation on Instagram</a></li></ul><p><br></p><p>Our podcast sponsor is Progyny Global. A company that provides best-in-class fertility, pregnancy, postpartum and menopause benefits for the modern global workforce. Progyny Global offers an inclusive platform that connects employees with top experts, clinics, and treatments around the world. To learn more visit: <a href=\"https://progynyglobal.com/#contact\" rel=\"noopener noreferrer\" target=\"_blank\">https://progynyglobal.com/#contact</a> or to get in touch with our team directly via email (<a href=\"mailto:Sasha.tory@progynyglobal.com\" rel=\"noopener noreferrer\" target=\"_blank\">Sasha.tory@progynyglobal.com</a>)</p><p><br></p>","author_name":"Leo Tyson"}